Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-02-02 00:00:00 ET · period of report 2026-02-02 · accession 0001468316-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-02 | 2026-02-02 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | +15.6K | 108.8K | +17% | +$38.2K |
| D | 2026-02-02 | 2026-02-02 | FENC | Raykov Rosty | Dir | S - Sale+OE | $7.76 | -10.3K | 98.5K | -10% | -$80.3K |
| D | 2026-02-02 | 2026-02-02 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | -15.6K | 1.60M | -1.0% | -$38.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-02-02 | M | A | 15,598 | $2.45 | 108,826 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025. |
| 2 | Common | Common shares | 2026-02-02 | S | D | 10,349 | $7.76 | 98,477 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Derivative | Stock Options | 2026-02-02 | M | D | 15,598 | $2.45 | 1,602,988 | D | $2.45 · 2016-07-05 to 2026-07-05 | 15,598 options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025. |